HLscience Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 28.60%

HLscience Co. Ltd (239610) has an Asset Resilience Ratio of 28.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 239610 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩25.60 Billion
≈ $17.35 Million USD Cash + Short-term Investments

Total Assets

₩89.51 Billion
≈ $60.66 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how HLscience Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is HLscience Co. Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down HLscience Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 239610 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩25.60 Billion 28.6%
Total Liquid Assets ₩25.60 Billion 28.60%

Asset Resilience Insights

  • Very High Liquidity: HLscience Co. Ltd maintains exceptional liquid asset reserves at 28.60% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

HLscience Co. Ltd Industry Peers by Asset Resilience Ratio

Compare HLscience Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for HLscience Co. Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for HLscience Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 10.88% ₩10.64 Billion
≈ $7.21 Million
₩97.78 Billion
≈ $66.26 Million
-13.94pp
2023-12-31 24.82% ₩26.30 Billion
≈ $17.82 Million
₩105.97 Billion
≈ $71.81 Million
-2.14pp
2022-12-31 26.96% ₩29.34 Billion
≈ $19.88 Million
₩108.82 Billion
≈ $73.74 Million
-21.85pp
2021-12-31 48.81% ₩57.53 Billion
≈ $38.99 Million
₩117.87 Billion
≈ $79.88 Million
-12.71pp
2020-12-31 61.52% ₩65.86 Billion
≈ $44.64 Million
₩107.06 Billion
≈ $72.55 Million
-1.58pp
2019-12-31 63.10% ₩59.58 Billion
≈ $40.38 Million
₩94.42 Billion
≈ $63.99 Million
-2.63pp
2018-12-31 65.74% ₩46.94 Billion
≈ $31.81 Million
₩71.41 Billion
≈ $48.39 Million
+4.59pp
2017-12-31 61.15% ₩35.30 Billion
≈ $23.93 Million
₩57.74 Billion
≈ $39.13 Million
-6.84pp
2016-12-31 67.99% ₩37.11 Billion
≈ $25.15 Million
₩54.58 Billion
≈ $36.99 Million
+51.26pp
2015-12-31 16.73% ₩2.91 Billion
≈ $1.97 Million
₩17.39 Billion
≈ $11.79 Million
+7.66pp
2014-12-31 9.07% ₩1.26 Billion
≈ $853.88K
₩13.89 Billion
≈ $9.41 Million
--
pp = percentage points

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$18.26 Million
₩26.94 Billion KRW
Market Cap Rank
#25488 Global
#1887 in Korea
Share Price
₩5290.00
Change (1 day)
-0.38%
52-Week Range
₩5090.00 - ₩11280.00
All Time High
₩105342.87
About

HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more